CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...